Active Ingredient: Semaglutide Semaglutide is a GLP-1 receptor agonist only
doi: 10.1210/en.2015-1168 5 GuidaCRamracheyaR
Someone with favorable genetic variants might maintain 40-50% of weight loss after stopping, while others regain more rapidly
Badger State Hydrate offers microdoses for GLP-1 treatments on a case-by-case basis
For some individuals, significant lifestyle changeslike consistent diet and exercisecan help maintain results and possibly reduce or eliminate the need for semaglutide
It really puts companies in a difficult spot. Dianne Munevar, head of Healthsperiens center for health, research, policy, and strategy, said that while telehealth companies offering prescription drugs would still fall under FDA jurisdiction, there are regulatory gray areas when these companies offer compounded medications that do not receive FDA approval. Munevar co-authored a study this year on ways to strengthen oversight of drug promotions on social media, suggesting the agency should clarify its regulatory authority under the Federal Food, Drug, and Cosmetic Act with respect to false and misleading advertising of compounded drugs